Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Soccio (Foggia, Italy), D. Lacedonia (Foggia, Italy), G. Carpagnano (Foggia, Italy), G. Palladino (Foggia, Italy), C. Incoronata (Foggia, Italy), F. Simone (Foggia, Italy), R. Termine (Foggia, Italy), S. Stornelli (Foggia, Italy), M. Foschino-Barbaro (Foggia, Italy). Systemic and local expression of Mithocondrial DNA and Periostin in IPF. 4698

Member's Comments

No comment yet.

Related content which might interest you: Increased mRNA expression of collagen V gene in pulmonary fibrosis of systemic sclerosis Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009 High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 454s Year: 2004 Increased cytokeratin-19 expression in fibrotic interstitial lung disease Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Chemokine mRNA expression profiling in pulmonary sarcoidosis Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis Year: 2008 Expression of mRNA of selected inflammatory markers in BALf cells from patients with sarcoidosis and idiopathic pulmonary fibrosis (IPF) Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017 Pulmonary gene expression of tenascin-C and fibronectin in chronic obtructive pulmonary disease (COPD) Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012 Pleural and systemic cytokine expression profiles in patients with lung cancer Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018 Microarray analysis reveals NFIB as a potential target of the matricellular protein WISP1 in alveolar epithelial cells in idiopathic pulmonary fibrosis Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis Year: 2009 NHLRC2 mRNA and protein expression in idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021 microRNA-34a and microRNA 199a-5p in COPD and their control of HIF-1α expression in pulmonary vasucular endothelial cells Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease Year: 2011 Differential expression of IL-33 and HMGB1 in the lungs of stable cystic fibrosis patients Source: Eur Respir J 2014; 44: 802-805 Year: 2014 Differential expression of telomerase activity in patients with autoimmune pulmonary fibrosis in BALF Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease Year: 2010 Expression profiling in sarcoidosis, EAA and IPF Source: Annual Congress 2010 - Different patterns of interstitial lung disease Year: 2010 Expression of hyaluronidase by interstitial myofibroblasts and epithelial cells is associated with fibrosis extension, clinical forms and pulmonary function stage in patients with systemic sclerosis Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Low expression of cellular retinoic acid binding protein 2 and dysregulation of elastin expression in pulmonary emphysema fibroblasts Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008 Aberrant expression and activity of histone deacetylases in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 ETS-1 mRNA and its association with T-BET and Th1 cytokine expression in active pulmonary sarcoidosis. Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018 A role of Foxc2 gene in mice with bleomycin-induced pulmonary fibrosis Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Inhibition of profibrotic signaling in fibroblasts from patients with idiopathic pulmonary fibrosis (IPF) by histone deacetylase-inhibitors (HDACi) or the IPF drug pirfenidone Source: International Congress 2014 – ILDs 1 Year: 2014 Gene expression and cellular profiling in a rat bleomycin model of drug-induced interstitial lung disease (DIILD) Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020